title: Reduced dose of tocilizumab for the maintenance of remission in patients with rheumatoid arthritis: a clinical experience.
authors.affiliation: Rheumatology Unit, Niguarda Ca' Granda Hospital, Piazza Ospedale Maggiore 3, 20162, Milan, Italy, oscar.epis@ospedaleniguarda.it.
authors.forename: Oscar
authors.initials: O
authors.lastname: Epis
authors.forename: Cinzia
authors.initials: C
authors.lastname: Casu
authors.forename: Laura
authors.initials: L
authors.lastname: Belloli
authors.forename: Emanuela
authors.initials: E
authors.lastname: Schito
authors.forename: Davide
authors.initials: D
authors.lastname: Filippini
authors.forename: Marina
authors.initials: M
authors.lastname: Muscarà
authors.forename: Eleonora
authors.initials: E
authors.lastname: Bruschi
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage* / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans; D012074:Remission Induction; D012720:Severity of Illness Index; D016896:Treatment Outcome
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents; C502936:tocilizumab